On February 22, 2023 Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, reported that management will present at the following investor conferences (Press release, Tyra Biosciences, FEB 22, 2023, View Source [SID1234627539])
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cowen 43rd Annual Healthcare Conference
Todd Harris, CEO of TYRA, will participate in a fireside chat on Tuesday, March 7, 2023 at 10:30 am ET
Oppenheimer 33rd Annual Healthcare Conference
Mr. Harris will virtually present a company overview on Wednesday, March 15, at 12:00 pm ET
Live and archived webcasts of the events will be available via the For Investors page on the Investor section of the TYRA website.